000064376 001__ 64376
000064376 005__ 20190709135627.0
000064376 0247_ $$2doi$$a10.2340/00015555-2760
000064376 0248_ $$2sideral$$a103619
000064376 037__ $$aART-2017-103619
000064376 041__ $$aeng
000064376 100__ $$aLesner, K.
000064376 245__ $$aDeterminants of psychosocial health in psoriatic patients: A multinational study
000064376 260__ $$c2017
000064376 5060_ $$aAccess copy available to the general public$$fUnrestricted
000064376 5203_ $$aThere are limited data on the differences in the impact of psoriasis between various countries with respect to quality of life (QoL). The aim of this study was to explore the psychosocial health of patients with psoriasis in different European countries. A total of 682 patients were recruited in 13 European countries. All patients completed a questionnaire regarding sociodemographic information, negative life events, suicidal ideation and satisfaction with their dermatologist. Depression and anxiety were assessed with the Hospital Anxiety and Depression Scale (HADS), and QoL with the Dermatology Life Quality Index (DLQI) and EuroQoL (EQ-5D). The lowest anxiety and depression scoring was noted in patients from Denmark, the lowest level of impairment in QoL in subjects from Spain, and the highest level of impairment in QoL in patients from Italy. The most relevant parameters influencing patients’ well-being were severity of pruritus and satisfaction with their dermatologist. The level of anxiety and depression symptoms correlated significantly with suicidal ideation.
000064376 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000064376 590__ $$a3.127$$b2017
000064376 591__ $$aDERMATOLOGY$$b12 / 63 = 0.19$$c2017$$dQ1$$eT1
000064376 592__ $$a1.089$$b2017
000064376 593__ $$aMedicine (miscellaneous)$$c2017$$dQ1
000064376 593__ $$aDermatology$$c2017$$dQ1
000064376 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000064376 700__ $$aReich, A.
000064376 700__ $$aSzepietowski, J.C.
000064376 700__ $$aDalgard, F.J.
000064376 700__ $$aGieler, U.
000064376 700__ $$0(orcid)0000-0003-1917-6906$$aTomas-Aragones, L.$$uUniversidad de Zaragoza
000064376 700__ $$aLien, L.
000064376 700__ $$aPoot, F.
000064376 700__ $$aJemec, G.B.
000064376 700__ $$aMisery, L.
000064376 700__ $$aSzabó, C.
000064376 700__ $$aLinder, D.
000064376 700__ $$aSampogna, F.
000064376 700__ $$aEvers, A.W.M.
000064376 700__ $$aHalvorsen, J.A.
000064376 700__ $$aBalieva, F.
000064376 700__ $$aLvov, A.
000064376 700__ $$aMarron, S.E.
000064376 700__ $$aAltunay, I.K.
000064376 700__ $$aFinlay, A.Y.
000064376 700__ $$aSalek, S.S.
000064376 700__ $$aKupfer, J.
000064376 7102_ $$14009$$2735$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicolog.Evolut.Educac
000064376 773__ $$g97, 10 (2017), 1182-1188$$pActa derm.-venereol.$$tACTA DERMATO-VENEREOLOGICA$$x0001-5555
000064376 8564_ $$s348413$$uhttps://zaguan.unizar.es/record/64376/files/texto_completo.pdf$$yVersión publicada
000064376 8564_ $$s147808$$uhttps://zaguan.unizar.es/record/64376/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000064376 909CO $$ooai:zaguan.unizar.es:64376$$particulos$$pdriver
000064376 951__ $$a2019-07-09-12:31:31
000064376 980__ $$aARTICLE